Market Executive Summary

REPORT HIGHLIGHT
The blood culture test market is estimated to represent a global market of USD 3,021 million by 2017 with growth rate of 8.1%.

Blood culture tests are widely used to detect the presence of foreign invaders, i.e. fungi or bacteria in blood samples. These cultures are collected for testing in order to check the cause of various infections inpatient. As per the article published in the Journal of Clinical Microbiology, every year, more than 20 million blood cultures are ordered in the U.S. alone.

Market Dynamics

Technological advancements are expected to be a major factor driving the market growth. Advancement in technologies has helped this field to provide better accuracy, reliability in disease diagnosis and to avoid unnecessary healthcare costs. For instance, an introduction of an automated microbial detection system, BacT ALERT 3D (bioMerieux) allows immediate bottle recognition with a low false positive rate and rapid response rate. This system is easy to use, save time, and prevent major test errors. Similarly, development of technologies targeted real-time PCR technique, and peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) plays a strategic role in fostering the change of blood culture industry towards better health outcomes.

In addition, rising number of hospital admissions has led to rise in the incidence of hospital-acquired infections. For example, according to the World Health Organization (WHO), hospital-acquired infection is the most frequent adverse event in healthcare delivery across the globe. The organization stated that of the 100 hospitalized patients, 10 in developing and 7 in developed region acquire at least one healthcare-associated infection every year. Thus, the demand for effective and advanced blood testing techniques appear to be growing at strong growth rate for the treatment and diagnosis of various infectious diseases, augmenting the market growth. On contrary, the market has been stifled by some key barriers to growth. The foremost among these is the strict regulatory requirements and a high cost for some laboratory methods.

Product Takeaway

In terms of products, the market is categorized into instrument, consumables, and services. Consumables segment accounted for the largest share of the total market, captured more than 56% in 2017. This segment is further classified into Media, Assay kits and reagents, and Accessories. Whereas, instrument segment is divided into laboratory equipment and automated blood culture systems. Depending upon technique, the market is segmented as conventional and automated. With the convergence of various scientific and technological breakthroughs, the pace of automated blood culture test segment is accelerating.

Global Blood Culture Test Market by Product, 2017 vs 2028



Technology Takeaway

Technology segment is categorized into Molecular, Culture-based and Proteomic. Some of the molecular technologies covered under this segment are a microarray, PCR, and PNA-FISH, The application segment is classified as Fungal Infections, Bacterial Infections, and others. Reference Laboratories, Hospitals, and others are considered under end-user segment.

Regional Takeaway

Regionally, the global industry is dominated by the North America market. In 2017, this region is accounted for more than 42% share of the total industry. The growth of the regions is primarily attributed to the increasing incidence of infectious diseases coupled with the growing demand. On contrary, currently, this industry in developing regions such as the Asia Pacific and Latin America is small but rapidly expanding.

Key Vendor Takeaway

Companies such as Thermo Fisher Scientific, bioMerieux, Abbott, Alere, and Bruker are profiled in the study. Majority of these companies were witnessed to have an extensive product offering coupled with strong regional presence. The key player is profiled based on attributes such as company overview, financial performance, SWOT analysis, and key developments.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year ? 2017 ? 2021
Base Year ? 2021
Estimated Year ? 2022
Projected Year ? 2028
TARGET AUDIENCE

Traders, Distributors, and Suppliers
Manufacturers
Hospitals
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY PRODUCT

Instrument
Laboratory Equipment
Automated Blood Culture
Consumables
Media
Assay kits and Reagents
Accessories
Services
MARKET, BY TECHNIQUE

Conventional
Automated
MARKET, BY TECHNOLOGY

Molecular
Culture-based
Proteomic
MARKET, BY APPLICATION

Fungal Infections
Bacterial Infections
Others
MARKET, BY END USE

Reference Laboratories
Hospitals
Others
MARKET, BY REGION

North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America